Shenzhen Edge Medical Co., Ltd. (HKG:2675)

Market Cap	21.16B
Revenue (ttm)	507.12M +184.8%
Net Income	-98.60M
EPS	-0.27
Shares Out	391.88M
PE Ratio	n/a
Forward PE	288.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,600
Open	53.30
Previous Close	53.50
Day's Range	51.90 - 54.90
52-Week Range	48.00 - 73.70
Beta	n/a
Analysts	Buy
Price Target	81.17 (+49.65%)
Earnings Date	Mar 27, 2026

About Shenzhen Edge Medical

Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted devic...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Employees: 602
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2675

Financial Performance

In 2025, Shenzhen Edge Medical's revenue was 455.72 million, an increase of 184.83% compared to the previous year's 159.99 million. Losses were -88.61 million, -59.45% less than in 2024.

Financial numbers in CNY